“Once daily OCS-01, an OPTIREACH® formulation of high concentration dexamethasone eye drop, for Inflammation Following Cataract Surgery - a Phase-3 Double Masked, Vehicle Controlled Study”
Apr 5 - Apr 8, 2024
“OCS-01 Dexamethasone Eye Drops QD for Inflammation Following Cataract Surgery- a Phase-3 Double Masked, Vehicle Controlled Study” by Eric Donnenfeld, MD on behalf of the study group.
Presentation date and time: April 7, at 4:45pm EST
Location
Boston Convention and Exhibition Center – Meeting Level 2, Room 257A